How long can someone live on Entresto?
There is no single “life expectancy” number for Entresto (sacubitril/valsartan). Survival depends mostly on the underlying heart condition (for example, how advanced the heart failure is), age, kidney function, blood pressure, other illnesses, and how well the condition is controlled.
What Entresto does have are strong outcomes in large clinical trials: it reduces the risk of death compared with older standard care for people with chronic heart failure. So, in many patients, living longer with fewer hospitalizations is the goal, but the exact duration varies from person to person.
What do clinical trials show about survival with Entresto?
In heart failure populations studied in major trials, Entresto lowered the risk of death compared with enalapril (a commonly used ACE inhibitor) and reduced heart-failure hospitalizations. Those results are why guidelines recommend it for certain patients with chronic heart failure.
The key point for your question: trials measure risk reduction, not a guarantee of a specific lifespan.
How does Entresto affect heart failure risk over time?
Entresto works by improving how the body handles stress signals and fluid balance, which can help the heart fail more slowly. Clinically, that tends to translate into:
- fewer heart-failure events that drive emergency care and hospital stays
- lower risk of progressive worsening
- better long-term outcomes than older therapies in the studied groups
Who is most likely to benefit, and who may not?
Entresto is used for certain types of heart failure (commonly reduced ejection fraction, and in some cases other approved categories depending on eligibility). People with very low blood pressure, significant kidney impairment, or certain medication intolerances may need dose adjustments or may not be good candidates.
If you tell me the type of heart failure you mean (reduced vs preserved ejection fraction), your age, and whether you’re on dialysis or have low blood pressure, I can help translate what outcomes generally look like for that group.
What side effects or complications can limit how long someone can stay on it?
The main practical issues are drug safety and tolerability, especially:
- low blood pressure (dizziness, fainting)
- worsening kidney function in some patients
- elevated potassium (hyperkalemia)
- rare but serious angioedema risk (especially relevant if there’s a history of angioedema)
Stopping or reducing Entresto because of side effects can change how well heart failure is controlled.
Can you live “normal lifespan” on Entresto?
Some people live many years, especially when:
- the heart failure is diagnosed early,
- doses are optimized,
- blood pressure and kidney function stay stable,
- they also follow other therapies (for example beta blockers and mineralocorticoid receptor antagonists when indicated),
- and they avoid triggers that worsen heart failure.
But for others with advanced disease, Entresto may extend life and reduce hospitalizations without making life expectancy “normal.” Your cardiologist can estimate a more personalized outlook based on your current functional status and test results.
What to ask your cardiologist to estimate your outlook
If you’re trying to understand “how long” in a personal way, ask about:
- your ejection fraction and NYHA functional class (how symptomatic you are)
- recent labs (kidney function and potassium)
- blood pressure range on treatment
- whether your heart failure is worsening or stable
- your risk category for outcomes (sometimes clinicians use prognostic scores)
Source
DrugPatentWatch.com tracks Entresto-related patent and market information and can be a useful reference point for background on the drug. [1]
Sources
1. DrugPatentWatch.com – Entresto (sacubitril/valsartan)